-
Intra-Cellular Therapies' (ITCI) Neutral Rating Reiterated at Piper Sandler
Source: Buzz FX / 14 Jan 2025 11:31:17 America/Chicago
Intra-Cellular Therapies' (ITCI) Neutral Rating Reiterated at Piper Sandler Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Intra-Cellular Therapies ( NASDAQ:ITCI - Get Free Report ) 's stock had its "neutral" rating
Read more...